 |
 The Team
CLAUDIA WIATR
Senior Analyst
Claudia Wiatr came to Wolters Kluwer from Thomson Reuters
where she was a Principal in the Healthcare group of Reuters
Primary Research, based in London, UK.
Her primary focus is
on CNS, specifically pain, addiction, ADHD, Schizophrenia.
Ms. Wiatr also covered medical technology, devices, orthopedics
and diagnostics. Ms. Wiatr joined Reuters from the Life Sciences
equity research team at Panmure Gordon in London, a division
of Lazard Frères, where she headed the group’s coverage of
small and mid-cap European companies. Prior to Panmure, Ms.
Wiatr was an analyst within Credit Suisse First Boston’s (now
Credit Suisse) Investment Banking Healthcare Group in London
and a Senior Consultant within the Health Industry practice
of Arthur D. Little, in Cambridge, Massachusetts where she
focused on strategic and financial decisions for European and
US life science companies.
Ms. Wiatr graduated from Tufts University with a bachelor’s degree
in Psychology and concentration in Nutritional Psychopharmacology.
She completed graduate courses in Immunology at Harvard Medical
School and holds a M.Sc. in Corporate Finance and International
Accounting from the London School of Economics.
|
|
